Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Dow
Baxter
Moodys
Accenture
Cipla
Harvard Business School
UBS
Cantor Fitzgerald
Cerilliant

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 073262

« Back to Dashboard

NDA 073262 describes SULINDAC, which is a drug marketed by Ani Pharms Inc, Epic Pharma, Epic Pharma Llc, Fosun Pharma, Mylan, Sun Pharm Industries, and Watson Labs, and is included in twelve NDAs. It is available from twenty-one suppliers. Additional details are available on the SULINDAC profile page.

The generic ingredient in SULINDAC is sulindac. There are fourteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the sulindac profile page.
Summary for 073262
Tradename:SULINDAC
Applicant:Epic Pharma Llc
Ingredient:sulindac
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 073262
Medical Subject Heading (MeSH) Categories for 073262
Suppliers and Packaging for NDA: 073262
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SULINDAC sulindac TABLET;ORAL 073262 ANDA Heritage Pharmaceuticals Inc. 23155-005 E 23155-005-05
SULINDAC sulindac TABLET;ORAL 073262 ANDA Heritage Pharmaceuticals Inc. 23155-005 E 23155-005-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength200MG
Approval Date:Sep 6, 1991TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength150MG
Approval Date:Sep 6, 1991TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Federal Trade Commission
Fish and Richardson
Fuji
Julphar
Moodys
Citi
Mallinckrodt
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot